Functional dyspepsia: Past, present, and future

Journal of Gastroenterology

Volumn 43, Issue 4, 2008, Pages 251-255

  Geeraerts, Brecht ^a   Tack, Jan ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Early satiation; Epigastric pain syndrome (EPS); Postprandial distress syndrome (PDS); Postprandial fullness; Rome III consensus

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT;

CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DYSPEPSIA; EPIGASTRIC BURNING; EPIGASTRIC PAIN; FUNCTIONAL DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HUMAN; IRRITABLE COLON; NOMENCLATURE; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SATIETY; SYMPTOM; TREATMENT OUTCOME;

DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HUMANS; PREVALENCE; WORLD HEALTH;

EID: 43249118223     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2167-8     Document Type: Review

References (30)

1. Drossman DA. The Rome Foundation and Rome III. Neurogastroenterol Motil 2007;19:783-786.
2. Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, Gugler R, et al. Management of dyspepsia: Report of a working party. Lancet 1988;1:576-579.
3. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, Johnson AG, et al. Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci 1989;34:1272-1276.
4. Talley NJ, Koch KL, Koch M, et al. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastrointest Int 1991;4:145-160.
5. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999;45(Suppl) II:37-42.
6. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu PJ, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
7. Stanghellini V. Review article: Pain versus discomfort - is differentiation clinically useful? Aliment Pharmacol Ther 2001;15:145-149.
8. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004;127:1239-1255.
9. Laheij RJ, De Koning RW, Horrevorts AM, Rongen RJ, Rossum LG, Witteman EM, et al. Predominant symptom behavior in patients with persistent dyspepsia during treatment. J Clin Gastroenterol 2004;38:490-495.
10. Talley NJ, Locke GR 3rd, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006;55:933-939.
11. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: A population-based study. Scand J Gastroenterol 2002;37:917-923.
12. Fischler B, Vandenberghe J, Persoons P, De Gucht V, Broekaert D, Luyckx K, et al. Evidence-based subtypes in functional dyspepsia with confirmatory factor analysis: Psychosocial and physiopathological correlates. Gastroenterology 2003;124:903-910.
13. Tack J, Talley NJ, Coulie B, Dubois D, Jones M. Association of weight loss with gastrointestinal symptoms in a tertiary-referred patient population. Gastroenterology 2003 (abstract).
14. Jones M, Talley N, Coulie B, Dubois J, Tack J. Association of weight loss with gastrointestinal symptoms. Gastroenterology 2003 (abstract).
15. Kwan AC, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003;18:796-802.
16. Whitehead WE, Bassotti G, Palsson O, Taub E, Cook EC III, Drossman DA. Factor analysis of bowel symptoms in US and Italian populations. Dig Liv Dis 2003;35:774-783.
17. Camilleri M, Dubois D, Coulie B, Jones M, Stewart WF, Sonnenberg A, et al. Results from the US upper gastrointestinal study: Prevalence, socio-economic impact and functional gastrointestinal disorder subgroups identified by factor and cluster analysis. Clin Gastroenterol Hepatol 2005;3:543-552.
18. Piessevaux H, De Winter B, Louis E, Muls V, De Looze D, Pelckmans P, et al. Dyspeptic symptoms in the general population: A factor and cluster analysis of symptom groupings. 2008 (submitted).
19. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004;2:985-996.
20. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-1029.
21. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: Two double-blind, randomized, placebo-controlled trials. Am J Med 2004;116:740-748.
22. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence and symptomatic impact of non-erosive reflux disease in functional dyspepsia. Gut 2005;10:1370-1376.
23. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-1065.
24. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 2004;127:1329-1337.
25. Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004;99:1152-1159.
26. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006 Apr 19;(2):CD002096.
27. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 2004;127:1329-1337.
28. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006 Oct 18;(4):CD001960.
29. Hiyama T, Yoshihara M, Matsuo K, Kusunoki H, Kamada T, Ito M, et al. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J Gastroenterol Hepatol 2007;22:304-310.
30. Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, Kawabe M, et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: Systematic review. J Gastroenterol 2005;40:1036-1042.